<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03525990</url>
  </required_header>
  <id_info>
    <org_study_id>2017/01</org_study_id>
    <nct_id>NCT03525990</nct_id>
  </id_info>
  <brief_title>Study Evaluating the Impact of Electronic Surveys on Patient-physician Communication and Quality of Life in Breast Cancer Patients</brief_title>
  <official_title>PRO-COM Project: Randomized-controlled Study Evaluating the Impact of Electronic Patient Reported Outcome (ePRO) Surveys on Patient-physician Communication and Quality of Life in Patients With Advanced Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Vera Trommet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum Wels-Grieskirchen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PRO-COM Project: Randomized-controlled study evaluating the impact of electronic patient
      reported outcome (ePRO) surveys on patient-physician communication and quality of life in
      patients with advanced breast cancer
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2018</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient-physician communication</measure>
    <time_frame>Up to six months</time_frame>
    <description>The communication between patient and physician will be assessed with EORTC QLQ-COMU26. Presumably some patients have privacy concerns with electronic questionnaires. The EORTC-COMU26 is the most important questionnaire in this study because it is needed for the primary endpoint. It contains sensitive questions about how the patient experiences the communication during the visit. In order to avoid patients not filling out the questionnaire due to privacy concerns or being afraid of giving an honest opinion and the physician could read it electronically, the EORTC QLQ-COMU26 is paper-based and the patients can hand them in in the study office.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Arm A: at every visit for six months; Arm B: at baseline, three months, six months</time_frame>
    <description>Quality of life will be assessed electronically with EORTC QLQ-C30.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of discontinuations of therapy</measure>
    <time_frame>Up to six months</time_frame>
    <description>The frequency of discontinuations will be assessed based on medical reports.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of communication between physician and patient</measure>
    <time_frame>At baseline, three months, six months in both groups</time_frame>
    <description>Physicians call the study office at the beginning and at the end of the consultation at baseline, three months and six months. They will record the duration of the consultation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Breast Neoplasm Malignant Female</condition>
  <arm_group>
    <arm_group_label>Intervention Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Quality of life questionnaires (electronic patient reported outcomes) to be filled out by the patients at every visit. Quality of life data is fully available for physicians. Paper-based questionnaire (EORTC QLQ-COMU26) at baseline, after three months and after six months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Quality of life questionnaires (electronic patient reported outcomes) only to filled out by the patients at baseline, after three months and after six months. Quality of life data is hidden for physicians. Paper-based questionnaire (EORTC QLQ-COMU26) at baseline, after three months and after six months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Quality of life questionnaires on iPads with CHES (Computer-based Health Evaluation System), paper-based questionnaire (EORTC QLQ-COMU26)</description>
    <arm_group_label>Intervention Arm</arm_group_label>
    <arm_group_label>Control Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stage IV breast cancer

          -  Start of a systemic anti cancer therapy: chemotherapy -/+ antibody therapy 1st until
             3rd line (palliative), endocrine therapy or other therapy without limit

          -  Estimated life expectancy of minimum six months

          -  Signed informed consent

          -  No cognitive or speech impairments
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vera Trommet, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum Wels-Grieskirchen GmbH, 4. Interne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vera Trommet, Dr.</last_name>
    <phone>+437242415</phone>
    <phone_ext>92178</phone_ext>
    <email>vera.trommet@klinikum-wegr.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabella Rauscher, BSc.</last_name>
    <phone>+437242415</phone>
    <phone_ext>3452</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>A.ö. Krankenhaus St. Josef Braunau GmbH</name>
      <address>
        <city>Braunau Am Inn</city>
        <state>Upper Austria</state>
        <zip>5280</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gottfried Hasenöhrl, Prof. Dr.</last_name>
      <phone>+437722804</phone>
      <phone_ext>5800</phone_ext>
      <email>gottfried.hasenoehrl@khbr.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Wels-Grieskirchen GmbH</name>
      <address>
        <city>Wels</city>
        <state>Upper Austria</state>
        <zip>4600</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vera Trommet, Dr.</last_name>
      <phone>+437242415</phone>
      <phone_ext>92178</phone_ext>
      <email>vera.trommet@klinikum-wegr.at</email>
    </contact>
    <contact_backup>
      <last_name>Isabella Rauscher, BSc.</last_name>
      <phone>+437242415</phone>
      <phone_ext>3452</phone_ext>
      <email>isabella.rauscher@klinikum-wegr.at</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2018</study_first_submitted>
  <study_first_submitted_qc>May 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Wels-Grieskirchen</investigator_affiliation>
    <investigator_full_name>Dr. Vera Trommet</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

